CENCORA INC (COR) Stock Price, Forecast & Analysis
USA • New York Stock Exchange • NYSE:COR • US03073E1055
COR Key Statistics, Chart & Performance
The current stock price of COR is 361.35 USD. In the past month the price increased by 5.21%. In the past year, price increased by 48.37%.
COR Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to COR. When comparing the yearly performance of all stocks, COR is one of the better performing stocks in the market, outperforming 82.45% of all stocks.
COR Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to COR. Both the profitability and the financial health of COR get a neutral evaluation. Nothing too spectacular is happening here.
COR Financial Highlights
Over the last trailing twelve months COR reported a non-GAAP Earnings per Share(EPS) of 16.34. The EPS increased by 14.99% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.5% | ||
| ROA | 2.07% | ||
| ROE | 85.16% | ||
| Debt/Equity | 3.97 |
COR Forecast & Estimates
22 analysts have analysed COR and the average price target is 406.24 USD. This implies a price increase of 12.42% is expected in the next year compared to the current price of 361.35.
For the next year, analysts expect an EPS growth of 11.24% and a revenue growth 6.23% for COR
COR Ownership
COR Latest News, Press Relases and Analysis
COR Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 21.17 | 114.554B | ||
| CAH | CARDINAL HEALTH INC | 19.55 | 51.834B | ||
| HSIC | HENRY SCHEIN INC | 15.05 | 9.538B | ||
| AHCO | ADAPTHEALTH CORP | 10.34 | 1.441B | ||
| ACH | ACCENDRA HEALTH INC | 2.54 | 184.093M | ||
| WGRX | WELLGISTICS HEALTH INC | N/A | 27.072M |
Related stock screener links
View all stocks in the Health Care Distributors Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About COR
Company Profile
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 51,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Company Info
CENCORA INC
1 West First Avenue
Conshohocken PENNSYLVANIA 80202 US
CEO: Paul E. Szurek
Employees: 51000
Phone: 13026587581
CENCORA INC / COR FAQ
What does COR do?
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 51,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
What is the current price of COR stock?
The current stock price of COR is 361.35 USD. The price increased by 0.38% in the last trading session.
Does COR stock pay dividends?
CENCORA INC (COR) has a dividend yield of 0.66%. The yearly dividend amount is currently 2.25.
What is the ChartMill rating of CENCORA INC stock?
COR has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the Price/Earnings (PE) ratio of CENCORA INC (COR)?
The PE ratio for CENCORA INC (COR) is 22.11. This is based on the reported non-GAAP earnings per share of 16.34 and the current share price of 361.35 USD.
Can you provide the growth outlook for CENCORA INC?
The Revenue of CENCORA INC (COR) is expected to grow by 6.23% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the ownership details for COR stock?
You can find the ownership structure of CENCORA INC (COR) on the Ownership tab.